Benign Prostatic Hyperplasia - Drug Pipeline Landscape, 2022 | AiViva BioPharma, Antev Ltd., ASKA Pharmaceutical Co., Ltd, Ausio Pharmaceuticals, LLC, Dongkook Pharmaceutical

Global Insight Services have recently published a report on Benign Prostatic Hyperplasia landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.

Benign Prostatic Hyperplasia (BPH) also called as prostate gland enlargement, is a noncancerous increase in size of the prostate gland. An enlarged prostate gland can cause uncomfortable urinary symptoms, such as blocking the flow of urine out of the bladder.
The common causes of BPH include changes in male sex hormones, any family history of prostate problems or any abnormalities with testicles risk of BPH.
Symptoms include incomplete bladder emptying, leakage of urine, obstructing the flow of urine, frequent or urgent need to urinate, increased frequency of urination at night (nocturia), difficulty starting urination, dribbling at the end of urination.
To know more about Benign Prostatic Hyperplasia, visit - https://www.globalinsightservices.com/reports/benign-prostatic-hyperplasia-drug-pipeline-landscape-2022/

Key Players :
• AiViva BioPharma
• Antev Ltd.
• ASKA Pharmaceutical Co., Ltd
• Ausio Pharmaceuticals, LLC
• Dongkook Pharmaceutical Co., Ltd.
• GemVax & Kael
• Health Ever Bio-Tech Co., Ltd.
• Nymox Corporation
• Urovant Sciences GmbH

Report Segmentation :
Assessment by Stage of Development
Assessment by Companies
Assessment by Target
Assessment by Mechanism of Action
Assessment by Molecule Type
Assessment by Route of Administration

Request for a PDF sample copy of report: https://www.globalinsightservices.com/request-sample/GIS31030

Report Highlights

Global Insight Service's, Benign Prostatic Hyperplasia - Drug Pipeline Landscape, 2022 report provides an overview of the Benign Prostatic Hyperplasia drugs. This report covers detailed insights on Benign Prostatic Hyperplasia drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Benign Prostatic Hyperplasia report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.

Buy this report: https://www.globalinsightservices.com/inquiry-before-buying/GIS31030

With Global Insight Services, you receive:

• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.